Tune In Virtually
Saturday, August 22nd – 10:00 AM – 12:30 PM ET
Wednesday, October 7th – 7:00 PM – 9:30 PM ET
Thursday, December 3rd – 7:00 PM – 9:30 PM ET
Overview
The Stanford Retina Innovation Summit will take place virtually over 3 sessions. The summit series will focus exclusively on the latest, game-changing innovations in medical and surgical retina, imaging, and pharmacotherapy. Topics will include the latest retina pharmacotherapy clinical trials data, updates on artificial intelligence (AI) for diagnosis, advances in molecular surgery for the precision treatment of previously untreatable blinding diseases, and novel drug delivery technologies designed to improve patient care. The program will also focus on the role of imaging in determining new biomarkers for disease. Surgical innovation will be addressed in terms of new instrumentation, visualization enhancements, and image-guided surgery.
This meeting will showcase the journey and insights of leaders in retinal innovation, with the goal of equipping retina specialists to work collaboratively to solve unmet needs for our patients.
Target Audience
- Medical and Surgical Retina Specialists
- Comprehensive Ophthalmologists
- Retina Fellows in Training
- Vision Researchers
Topic Highlights
- National and international faculty
- Innovation and retina practice: How you and your partners can achieve more through entrepreneurship
- Hurdles in new drug development: How to combat ocular inflammation
- Next generation therapies coming to your clinic
- Molecular surgery: Is this the future?
- Gene therapy is great: But is it safe?
- Key insights from top innovators in retina
- Game changing therapeutics
- How will Artificial Intelligence change your practice?
- A.I. in retina: Silicon Valley disruption
- Incorporating innovative advances in retinal imaging into clinical practice
Guest Faculty
Thomas A. Albini, MD
University of Miami
Miami, FL
David S. Boyer, MD
Retina-Vitreous Associates Medical Group
Beverly Hills, CA
Peter Campbell, MD, MPH
Casey Eye Institute
Portland, OR
Wiley Chambers, MD
U.S. Food and Drug Administration | FDA · Center for Drug Evaluation and Research
Silver Spring, MD
R.V Paul Chan, MD, MSc, MBO, FACS
University of Illinois
Chicago, IL
Grace C. Chang, MD, PhD
Oxurion
Iselin, NJ
Victor Chong, MBChB, MPhil, MD, FRCS, FRCOphth
University of Oxford
Headington, Oxford
Eugene De Juan, MD
UCSF Health
San Francisco, CA
Dean Eliott, MD
Massachusetts Eye and Ear
Boston, MA
Nancy Holekamp, MD
Pepose Vision Institute
Chesterfield, MO
Frank G. Holz, MD
University Hospital Bonn
Bonn, Germany
Glenn J. Jaffe, MD
Duke Eye Center
Durham, NC
Peter K. Kaiser, MD
Cole Eye Institute, Cleveland Clinic
Cleveland, OH
Pearse Keane, MD
Moorfields Eye Hospital
London, UK
Linda A. Lam, MD, MBA
Keck Medicine of USC
Los Angeles, CA
Stephen Odaibo, MD, MS (Math), MS (Comp. Sci.)
RETINA-Al Health, Inc. Houston, TX
Lynne Chou O’Keefe
Define Ventures
San Francisco, CA
Tushar M. Ranchod, MD
Bay Area Retina Associates
Walnut Creek, CA
Philip Rosenfeld, MD, PhD
University of Miami Health
Miami, FL
James Anthony Stefater, MD, PhD
Eye Health Services
East Weymouth, MA
Tomasz P. Stryjewski, MD
Tallman Eye Associates
Cambridge, MA
Cynthia A. Toth, MD
Duke Eye Center
Durham, NC
Adnan Tufail, MBBS, MD FRCOphth
London Retina Associates
London, KY
Charles C. Wykoff, MD, PhD
Retina Consultants of Houston
Houston, TX
David N. Zacks MD, PhD
Kellogg Eye Center
Ann Arbor, MI
Stanford Faculty
Mark S. Blumenkranz, MD
Stanford Health Care
Palo Alto, CA
Theodore Leng, MD FACS
Stanford Health Care
Palo Alto, CA
Loh-Shan B. Leung, MD
Stanford Health Care
Palo Alto, CA
Vinit B. Mahajan, MD, PHD
Stanford Health Care
Palo Alto, CA
Darius M. Moshfeghi, MD
Stanford Health Care
Palo Alto, CA
Carolyn Pan, MD
Stanford Health Care
Palo Alto, CA
Steven Sanislo, MD
Stanford Health Care
Palo Alto, CA
Ira H. Schachar, MD, MSc
Stanford Health Care
Palo Alto, CA
Ruwan A. Silva, MD, MPhil
Stanford Health Care
Palo Alto, CA
Edward H. Wood, MD
Stanford Health Care
Palo Alto, CA
Agenda
Session I Agenda
Session II Agenda
October 7, 2020 Agenda – TBD
Session III Agenda
December 3, 2020 Agenda – TBD
Registration Fees
We are happy to offer complimentary registration for all 3 live online sessions.
Sponsorship and Exhibit Information
For sponsorship and exhibit information, please contact Yaremi Koopot by email at ykoopot@ivistameded.com or by phone at +1-858-276-0003 for complete sponsorship opportunities and to request the program prospectus.
Accreditation Information
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and iVista Medical Education, Inc. Global is accredited by the ACCME to provide continuing medical education for physicians.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or danger in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and iVista Medical Education do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Credit Designation Statement
Global Education Group designates this activity for a maximum of 6 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by an educational grant from Alcon.
Stay Informed
Can't make this event? Subscribe here to stay informed on all upcoming events!
